<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-661
Date of Submission: 2024-08-15

This report was submitted by a Physician from Payne-Savage Medical Center concerning patient ANON-PX-1076. The subject is an adult other with a significant medical history including chronic kidney disease, atrial fibrillation, anxiety, coronary artery disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Omeprazole administered via the Intravenous route at a dosage of 485mg, initiated on 2024-06-19 for Gastroesophageal reflux disease and discontinued on 2024-07-13.

On approximately 2024-06-21, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Nausea. The Dizziness was classified as Life-threatening in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Unknown'. The Nausea was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Represent message green statement. Prevent operation important trip into.</data>
report_id: ADR-2024-661
report_date: '2024-08-15'
patient_details:
  patient_id: ANON-PX-1076
  gender: Other
  relevant_history:
  - chronic kidney disease
  - atrial fibrillation
  - anxiety
  - coronary artery disease
suspected_drugs:
- drug_name: Omeprazole
  dosage: 485mg
  route_of_administration: Intravenous
  start_date: '2024-06-19'
  indication_for_use: Gastroesophageal reflux disease
  end_date: '2024-07-13'
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-06-21'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
- symptom_name: Nausea
  onset_date: '2024-06-21'
  severity: Moderate
  outcome: Fatal
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
reporting_facility: Payne-Savage Medical Center
reporter_type: Physician
notes: Represent message green statement. Prevent operation important trip into.
